AstraZeneca Pharma shares gain 3% on CDSCO nod for expanded use of cancer drug Imfinzi

Shares of AstraZeneca Pharma India gained as much as 3 percent to Rs 6,890 in afternoon trade on March 3 after the company announced it has secured regulatory approval to…

Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr

Astrazeneca Pharma India advanced 1.21% to Rs 7557.05 after the company’s standalone net profit surged to Rs 54.68 crore in Q3 FY 25 as compared with Rs 15.80 crore in…